A Trial of Alemtuzumab Adjunctive Therapy in Allogeneic Hematopoietic Cell Transplantation with Minimal Conditioning for Severe Combined Immunodeficiency

For infants with severe combined immunodeficiency (SCID) the ideal conditioning regimen before allogeneic hematopoietic cell transplantation (HCT) would omit cytotoxic chemotherapy to minimize short- and long-term complications. We performed a prospective pilot trial with alemtuzumab monotherapy to...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Dvorak, Christopher C., Horn, Biljana N., Puck, Jennifer M., Adams, Stuart, Veys, Paul, Czechowicz, Agnieszka, Cowan, Morton J.
Formato: Artigo
Idioma:Inglês
Publicado em: 2014
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4134761/
https://ncbi.nlm.nih.gov/pubmed/24977928
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/petr.12310
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados